These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 727875

  • 1. [Mechanism of acute toxic effects of chlorocholine chloride and 2-chloroethyl phosphonic acid (Ethephon)].
    Hennighausen G, Tiefenbach B.
    Arch Exp Veterinarmed; 1978; 32(4):609-21. PubMed ID: 727875
    [Abstract] [Full Text] [Related]

  • 2. [Causes for species difference in acute toxicity of chlorocholine chloride].
    Hennighausen G, Tiefenbach B.
    Arch Exp Veterinarmed; 1977; 31(4):527-32. PubMed ID: 203241
    [Abstract] [Full Text] [Related]

  • 3. [Hygienic standards for chlorocholine chloride in the water of reservoirs].
    Vasilenko VE.
    Gig Sanit; 1978 Apr; (4):8-12. PubMed ID: 640442
    [No Abstract] [Full Text] [Related]

  • 4. [Hygienic evaluation of chlorcholinchloride (compound CCC) and its combination with 2, 4 D amine salt].
    Gorshkov AI.
    Gig Sanit; 1971 Nov; 36(11):33-6. PubMed ID: 5149190
    [No Abstract] [Full Text] [Related]

  • 5. [Hygienic standard for the chlorocholine chloride content of wheat grain].
    Agadzhanian SM.
    Vopr Pitan; 1982 Nov; (1):72-3. PubMed ID: 7072189
    [No Abstract] [Full Text] [Related]

  • 6. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert PanelCosmetic Ingredient Review, Washington DC 20036, USA..
    Int J Toxicol; 2008 Nov; 27 Suppl 1():1-43. PubMed ID: 18569160
    [Abstract] [Full Text] [Related]

  • 7. [Studies on toxicological and pharmacological properties of chlorcholine chloride (CCC) and N,N-dimethyl-(2-bromoethyl)-hydrazinium bromide (BMH)].
    Hennighausen G, Tiefenbach B, Dietrich C.
    Acta Biol Med Ger; 1974 Nov; 33(1):89-98. PubMed ID: 4418892
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of (2-hydroxyethyl)-trimethylammonium chloride (choline chloride - CC) on the resorption and excretion of chlorocholine chloride (CCC) in rats].
    Romanowski H.
    Ann Univ Mariae Curie Sklodowska Med; 1980 Nov; 35():33-41. PubMed ID: 7349084
    [No Abstract] [Full Text] [Related]

  • 9. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
    Cosmetic Ingredient Review Expert PanelCosmetic Ingredient Review, Washington DC 20036, USA..
    Int J Toxicol; 2007 Nov; 26 Suppl 2():79-112. PubMed ID: 17613133
    [Abstract] [Full Text] [Related]

  • 10. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007 Nov; 26 Suppl 1():3-106. PubMed ID: 17365137
    [Abstract] [Full Text] [Related]

  • 11. [The effect of 2-chlorethylphosphonic acid (ethephon) on the activity of cholinesterases in vivo and in vitro with reference to its acute toxicity].
    Hennighausen G, Tiefenbach B, Lohs Kh.
    Pharmazie; 1977 Mar; 32(3):181-2. PubMed ID: 866390
    [No Abstract] [Full Text] [Related]

  • 12. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?
    Maxwell DM, Brecht KM, Koplovitz I, Sweeney RE.
    Arch Toxicol; 2006 Nov; 80(11):756-60. PubMed ID: 16770629
    [Abstract] [Full Text] [Related]

  • 13. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y, Makino M, Usui C, Takasuna K, Kasai Y, Hirohashi M, Tamura K, Takayama S, Kojima H, Iizuka H.
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [Abstract] [Full Text] [Related]

  • 14. Effects of ingestion of chlorocholine chloride and cyclophosphamide on Venezuelan equine encephalitis virus infections in deer mice (Peromyscus maniculatus).
    Fairbrother A, Yuill TM, Olson LJ.
    Toxicology; 1984 May 01; 31(1):67-71. PubMed ID: 6729837
    [Abstract] [Full Text] [Related]

  • 15. [Embropathic effect of chlorocholine chloride CCC in the golden hamster].
    Juskiewicz T, Rakalska Z, Dzierzawski A.
    Eur J Toxicol; 1970 Sep 01; 3(5):265-70. PubMed ID: 5520480
    [No Abstract] [Full Text] [Related]

  • 16. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K.
    Arzneimittelforschung; 1995 Dec 01; 45(12):1274-84. PubMed ID: 8595084
    [Abstract] [Full Text] [Related]

  • 17. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K, Fujita S, Umezato M, Hosoki E, Toba Y, Kusunoki A, Shintani S.
    Arzneimittelforschung; 1992 Oct 01; 42(10):1200-11. PubMed ID: 1472141
    [Abstract] [Full Text] [Related]

  • 18. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K, Kimura T, Saeki I, Tabata R, Yamazaki S, Eguchi I, Hanazuka M, Horii D, Munt PL, Davis AS.
    Arzneimittelforschung; 1994 Jun 01; 44(6):715-26. PubMed ID: 8053970
    [Abstract] [Full Text] [Related]

  • 19. Cholinesterase inhibition and alterations of hepatic metabolism by oral acute and repeated chlorpyrifos administration to mice.
    Cometa MF, Buratti FM, Fortuna S, Lorenzini P, Volpe MT, Parisi L, Testai E, Meneguz A.
    Toxicology; 2007 May 05; 234(1-2):90-102. PubMed ID: 17382447
    [Abstract] [Full Text] [Related]

  • 20. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S, Ikezono K, Umezato M, Hosoki E, Toba Y, Ishikawa M, Kusunoki A, Shintani S.
    Arzneimittelforschung; 1992 Oct 05; 42(10):1212-22. PubMed ID: 1335257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.